MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Conversions
The Converter Site - unit conversion tool.
headlines news headlines   email email to a friend   printer printer friendly   newsletter sign up to newsletter  

Intubation For Emergency Airway Control In Critically Ill Patients Is Safer With Ketamine As A Sedative

Main Category: Clinical Trials / Drug Trials

Article Date: 01 Jul 2009

An article published Online First and in a future edition of The Lancet reports on the use of Ketamine as a safe and valuable substitute to conventional etomidate. It is used as a sedative during intubation. Critically ill patients frequently require tubing inserted into their airways to help control their breathing during treatment. The article is the work of Professor Frederic Adnet, SAMU 93, of the Hôpitaux de Paris, France, and his team.

There is evidence from prior studies that etomidate could be connected with increased mortality in patients with sepsis (blood stream infection). 655 patients were enrolled in this randomised controlled trial from twelve emergency departments and sixty five intensive care units in France. They all needed emergency intubation. 328 patients received 0.3 mg/kg etomidate and 327 patients received 2mg/kg ketamine. The endpoint of the trial was the maximum score of the sequential organ failure assessment (SOFA is a scoring system for assessment of in-hospital morbidity). Patients who died before reaching hospital or were discharged from intensive care within three days were excluded.

In total, 234 patients were analysed in the etomidate groups and 235 in the ketamine group. The average maximum SOFA score did not vary considerably between the two groups with 10.3 for the etomidate group, and 9.6 for the ketamine group. Also there was no significant difference in the difficulty of intubation between groups. However, adrenal insufficiency was reported in 86 percent of patients given etomidate, compared with just 48 percent of those given ketamine. Adrenal insufficiency is an acknowledged side effect of etomidate use. It is a condition in which the adrenal glands do not produce adequate amounts of steroid hormones which are chemicals produced by the body that regulate organ function. Adrenal insufficiency is probably associated with increased mortality in critically ill patients, although the reason for this has never been established. The authors mention that the cause for lower adrenal insufficiency in the ketamine group is probably related to other factors than just the sedative agent used.

The authors write in conclusion: "Our results show that ketamine is a safe and valuable alternative to etomidate for endotracheal intubation in critically ill patients, and should be considered in those with sepsis."

In a related note, Dr Volker Wenzel and Dr Karl H Lindner, from the Department of Anaesthesiology and Critical Care Medicine, Innsbruck Medical University, Austria, write: "In view of today's data, we might have to consider whether successful emergency intubation of critically ill patients depends not only on manual skills and clinical experience but also on pharmacological knowledge."

Drs. Wenzel and Lindner remark that the stricter policies of the European Government hold back studies of a non-commercial pathology such as multiple trauma, the number one cause of death in young adults. They write: "Our fate would be similar to physicians in developing countries, who have many questions about optimising health care but cannot do clinical trials to find valid answers."

"Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial"
Patricia Jabre, Xavier Combes, Frederic Lapostolle, Mohamed Dhaouadi, Agnes Ricard-Hibon, Benoit Vivien, Lionel Bertrand, Alexandra Beltramini, Pascale Gamand, Stephane Albizzati, Deborah Perdrizet, Gaelle Lebail, Charlotte Chollet-Xemard, Virginie Maxime, Christian Brun-Buisson, Jean-Yves Lefrant, Pierre-Edouard Bollaert, Bruno Megarbane, Jean-Damien Ricard, Nadia Anguel, Eric Vicaut, Frederic Adnet, on behalf of the KETASED Collaborative Study Group
DOI: 10.1016/S0140-6736(09)60949-1
thelancet

Written by Stephanie Brunner (B.A.)
Copyright: MediLexicon International Ltd

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.





For any corrections of factual information, or to contact the editors please use our feedback form.
Send your press releases to








free web search box


pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<




add to google

Add our searches to your Google homepage.

Add to Google

The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


Receive the latest medical news on your Google homepage.

Add to Google

The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions





Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
MediLexicon International Ltd © 2009 All rights reserved.